Dallas, TX 的 第二型糖尿病 臨床試驗
19 項針對 第二型糖尿病 的研究正在 Dallas（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
招募中3 期
- University of Texas Southwestern Medical Center, Dallas
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
招募中3 期
- North Texas Endocrine Center, Dallas
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Soltero Cardiovascular Research Center, Dallas
- North Texas Endocrine Center, Dallas
- Southwest Family Medicine Associates, Dallas
- 還有 1 項
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
招募中
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- Velocity Clinical Research, Dallas, Dallas
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
招募中2 期
- M3 Wake Research - Dallas, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Velocity Clinical Research, Dallas
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
招募中2 期
- University of Texas Southwestern Medical Center, Dallas
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
招募中2 期
- M3 Wake Research Dallas - Internal Medicine, Dallas
- Revival Research Institute, LLC, Dallas
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
招募中2 期
- Velocity Clinical Research - Dallas, Dallas
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Dallas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
招募中2 期
- Mercy Family Clinic, Dallas
- Velocity Clinical Research, Dallas, Dallas
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
招募中3 期
- Thyroid Endocrinology & Diabetes PA, Dallas
- Baylor Jack and Jane Hamilton, Dallas
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Dallas
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
招募中3 期
- Research Institute of Dallas, Dallas
Polypill for Prevention of Cardiomyopathy
招募中1/2 期
- UT Southwestern Medical Center, Dallas
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
招募中2 期
- Zenos Clinical Research, Dallas
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
招募中2 期
- Velocity Clinical Research Dallas, Dallas
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
招募中
- UT Southwestern Medical Center, Dallas
其他城市的 第二型糖尿病 試驗
- San Antonio, TX37 項研究
- Houston, TX31 項研究
- Orlando, FL25 項研究
- Boston, MA20 項研究
- Chicago, IL19 項研究
- Miami, FL19 項研究
- Columbus, OH18 項研究
- Las Vegas, NV18 項研究
- San Diego, CA17 項研究
- Atlanta, GA17 項研究
- Los Angeles, CA16 項研究
- Birmingham, AL16 項研究
Dallas 的其他研究
- 乳癌55 項研究
- 非小細胞肺癌52 項研究
- 轉移性癌症42 項研究
- 心臟衰竭42 項研究
- 癌症（所有類型）37 項研究
- 前列腺癌36 項研究
- 大腸直腸癌33 項研究
- 肥胖症30 項研究
- 卵巢癌28 項研究
- 肺癌27 項研究
- 膀胱癌27 項研究
- 子宮內膜癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。